Rituximab
Showing 2276 - 2300 of 2,665
Diabetes, Type 1 Trial in Belgium (ATG-MMF-TAC, ATG-Rituximab-MMF-TAC, ATG-basilixumab-MMF-TAC)
Unknown status
- Diabetes Mellitus, Type 1
- ATG-MMF-TAC
- +3 more
-
Antwerpen, Belgium
- +3 more
Dec 27, 2013
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in New Brunswick (rituximab, therapeutic allogeneic
Terminated
- Leukemia
- +2 more
- rituximab
- therapeutic allogeneic lymphocytes
-
New Brunswick, New JerseyCancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Me
Sep 13, 2013
Rituxan in Rheumatoid Arthritis AfterInadequate Response to
Completed
- Rheumatoid Arthritis
-
Birmingham, Alabama
- +192 more
Mar 26, 2015
B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Burkitt Lymphoma, Childhood Diffuse Large Cell Lymphoma Trial in
Terminated
- B-cell Childhood Acute Lymphoblastic Leukemia
- +8 more
- ifosfamide
- +7 more
-
Arcadia, CaliforniaChildren's Oncology Group
Oct 7, 2013
Lymphoma Trial in London (bleomycin sulfate, rituximab, prednisolone)
Unknown status
- Lymphoma
- bleomycin sulfate
- +3 more
-
London, England, United Kingdom
- +1 more
Sep 19, 2013
Cancer, Tumors, Lymphoma Trial in Edgbaston, Tremona Road, (Chi Lob 7/4 (A chimeric mAb))
Completed
- Cancer
- +4 more
- Chi Lob 7/4 (A chimeric monoclonal antibody)
-
Edgbaston, Birmingham, United Kingdom
- +1 more
Dec 1, 2014
Diffuse Large B-cell Lymphoma Trial in Shanghai (DA-EPOCH-R)
Terminated
- Diffuse Large B-cell Lymphoma
-
Shanghai, Shanghai, ChinaFudan University Cancer Hospital
Aug 19, 2014
Leukemia, Lymphocytic, Chronic, B-Cell Trial in Austria (Lenalidomide, Fludarabine, Rituximab)
Completed
- Leukemia, Lymphocytic, Chronic, B-Cell
- Lenalidomide
- +2 more
-
Innsbruck, Tirol, Austria
- +6 more
Aug 29, 2013
Lymphoma Trial in Nottingham (pegfilgrastim, rituximab, cyclophosphamide)
Unknown status
- Lymphoma
- pegfilgrastim
- +9 more
-
Nottingham, England, United KingdomNottingham City Hospital
Aug 23, 2013
Scleritis, Orbital Disease Trial in Portland (Rituximab)
Completed
- Scleritis
- Orbital Disease
- Rituximab
-
Portland, OregonOregon Health & Science University
Aug 8, 2013
Anemia, Hemolytic, Autoimmune Trial in Denmark (prednisolone + mabthera, Prednisolone)
Completed
- Anemia, Hemolytic, Autoimmune
- prednisolone + mabthera
- Prednisolone
-
Aalborg, Denmark
- +10 more
Sep 9, 2013
Non-Hodgkin's Lymphoma, Lymphoma Trial in Houston (Rituximab, Zevalin)
Completed
- Non-Hodgkin's Lymphoma
- Lymphoma
- Rituximab
- Zevalin
-
Houston, TexasUT MD Anderson Cancer Center
Sep 4, 2013
Lymphoma Trial in Birmingham, Stanford, Rochester (rituximab, yttrium Y 90 ibritumomab tiuxetan)
Terminated
- Lymphoma
- rituximab
- yttrium Y 90 ibritumomab tiuxetan
-
Birmingham, Alabama
- +2 more
Dec 12, 2013
Lymphoma Trial in Netherlands (filgrastim, rituximab, cyclophosphamide)
Unknown status
- Lymphoma
- filgrastim
- +5 more
-
's-Gravenhage, Netherlands
- +12 more
Sep 16, 2013
B-cell Chronic Lymphocytic Leukemia, Leukemia, Prolymphocytic Leukemia Trial in Boston (drug, biological, other)
Terminated
- B-cell Chronic Lymphocytic Leukemia
- +7 more
- obatoclax mesylate
- +3 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Sep 27, 2013
Lymphoma Trial in Shanghai (CEOP regimen, CHOP regimen)
Completed
- Lymphoma
- CEOP regimen
- CHOP regimen
-
Shanghai, Shanghai, ChinaFudan University Cancer Hospital
Aug 19, 2014
Recurrent Mantle Cell Lymphoma Trial in United States (rituximab, temsirolimus)
Completed
- Recurrent Mantle Cell Lymphoma
- rituximab
- temsirolimus
-
Mobile, Alabama
- +194 more
Mar 21, 2014
Hematological Malignancies Trial in Pavia
Unknown status
- Hematological Malignancies
-
Pavia, ItalyDepartment of Hematology Oncology, IRCCS Policlinico San Matteo
Jun 4, 2015
Rheumatoid Arthritis Trial in United States (Rituximab)
Completed
- Rheumatoid Arthritis
- Rituximab
-
Fort Lauderdale, Florida
- +5 more
Aug 21, 2013
Lymphoma Trial (biological, genetic, other)
Unknown status
- Lymphoma
- rituximab
- +6 more
- (no location specified)
Aug 1, 2013
Leukemia, Lymphoma, MDS Trial in Atlanta (biological, drug, procedure)
Terminated
- Leukemia
- +3 more
- alemtuzumab
- +8 more
-
Atlanta, GeorgiaBlood and Marrow Transplant Group of Georgia
Oct 28, 2013
END STAGE RENAL DISEASE Trial in Guadalajara (ESW group)
Completed
- END STAGE RENAL DISEASE
- ESW group
-
Guadalajara, Jalisco, MexicoUmae Hospital de Especialidades
Dec 26, 2014
Leukemia Trial in Rouen (Campath, rituximab, cyclophosphamide)
Completed
- Leukemia
- Campath
- +3 more
-
Rouen, FranceCentre Henri Becquerel
Jul 24, 2013